Recall
FDAHealthSeptember 17, 2024

Bionpharma Inc. — Atovaquone Oral Suspension, USP 750 mg/5 mL, 210 mL bottle, Rx only, Distributed by: Bionpharma Inc., Princeton, NJ 08540, NDC # 69452-252-87.

⚠️ Microbial Contamination of a Non-sterile Product: The product was found to be contaminated with Cohnella bacteria.

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
September 17, 2024

Nationwide in the U.S.A.

What's affected?

Product
Atovaquone Oral Suspension, USP 750 mg/5 mL, 210 mL bottle, Rx only, Distributed by: Bionpharma Inc., Princeton, NJ 08540, NDC # 69452-252-87.
UPC
0369452252871
Lot code
2310083

Additional details

Lot # 2310083, Exp. 09/30/2025

What should I do?

Recommended action

Class I recall. Voluntary: Firm initiated Quantity affected: 1,980 bottles.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.